Top Industry Leaders in the Competent Cells Market
Latest Competent cells Companies Update
-
May 2023: The world's top supplier of services and instruments for life-science research, GenScript Biotech Corporation, has extended its main oligonucleotide and peptide production plant in Zhenjiang, Jiangsu, China. The addition strengthens GenScript's standing as a global provider of high-quality oligo and peptides for scientists, having done so over 20 years. The increased capacity for oligonucleotide synthesis provides qPCR, NGS, RNA, and DNA oligos, among other oligos, to facilitate a variety of uses, including genome editing, RNA interference, and molecular diagnostics. With large-scale, high-throughput synthesizers, rigorous cross-contamination control methods via HPLC+ and PAGE+ purification processes, and ISO 13485 certification, GenScript can meet a wide range of application needs by offering up to 200nt DNA and 180nt RNA oligonucleotides at up to 95% purity, from ug to kilogram level.
-
Nov 2023: Along with a partner at Juntendo University School of Medicine, Takara Bio Inc. has reported the discovery of a novel adeno-associated virus (AAV) vector, named Sonuaav, that shows excellent gene transfer efficiency into inner ear tissues.
List of Competent cells Key companies in the market
- Thermo Fisher Scientific
- Merck KGaA
- Agilent Technologies, Inc.
- Takara Bio Inc.
- New England Biolabs (UK) Ltd.
- HiMedia Laboratories
- Zymo Research
- Avantor
- TransGen Biotech Co., Ltd
- Scarab Genomics
- Lucigen Corporation
- Genscript Corporation
- Tonbo Biosciences
- Enzynomics co Ltd
- Klee GmbH
- NZYTech, Lda